The post Nutriband Inc. (NTRB) reports Q1 loss, misses revenue estimates appeared on BitcoinEthereumNews.com.

Nutriband Inc. came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this company would post a loss of $0.12 per share when it actually produced a loss of $0.18, delivering a surprise of -50%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Nutriband, which belongs to the Zacks Medical – Drugs industry, posted revenues of $0.67 million for the quarter ended April 2025, missing the Zacks Consensus Estimate by 6.06%. This compares to year-ago revenues of $0.41 million. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call. Nutriband shares have added about 37.2% since the beginning of the year versus the S&P 500’s gain of 0.5%. What’s next for Nutriband? While Nutriband has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an…

---

Filed under: News - @ June 2, 2025 7:27 am